<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01497249</url>
  </required_header>
  <id_info>
    <org_study_id>FCHO 2011-086</org_study_id>
    <nct_id>NCT01497249</nct_id>
  </id_info>
  <brief_title>Assessing Fermentability of a Dietary Fiber</brief_title>
  <acronym>FCHO</acronym>
  <official_title>Assessing Fermentability of a Dietary Fiber (FCHO) in Healthy Non-obese Men and Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Nutrition Research Center, Illinois Institute of Technology</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ingredion Incorporated</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Clinical Nutrition Research Center, Illinois Institute of Technology</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to provide evidence for its fermentability of a dietary fiber&#xD;
      and to collect information regarding potential health opportunities for glucose control as&#xD;
      well as tolerability when being consumed over 7 days.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is designed as a randomized, 2-arm, treatment-controlled, within-subjects, 8-hour&#xD;
      postprandial crossover study, utilizing a multiple sampling paradigm to evaluate&#xD;
      fermentability and potential health opportunities for glucose control of a dietary fiber&#xD;
      (FCHO) in healthy non-obese men and women. The study will include 2 - 8 h assessments&#xD;
      following consumption of the FCHO drink or a placebo drink and will follow with a 7 day&#xD;
      feeding period to assess tolerability.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 1, 2011</start_date>
  <completion_date type="Actual">September 28, 2012</completion_date>
  <primary_completion_date type="Actual">September 28, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The fermentation action of a dietary fiber (FCHO) provided in a breakfast test meal in relatively healthy non-obese men and women</measure>
    <time_frame>8 hours</time_frame>
    <description>FCHO will be incorporated in a breakfast meal and compared to the same meal without the FCHO. Subjects will be served a breakfast meal with FCHO or without FCHO in a randomly assigned sequence on two separate occasions (visit 1 and visit 2) under fasting conditions.&#xD;
Hydrogen (H2) from breath will be measured before the breakfast test meal (baseline/fasting) and every hour: at 1hr, 2hr, 3hr, 4hr, 5hr, 6 hr, 7hr, and 8hr.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The changes in postprandial glucose concentrations after consuming test meals with FCHO drink compared to placebo drink</measure>
    <time_frame>8 hours</time_frame>
    <description>FCHO will be incorporated in a breakfast meal and compared to the same meal without the FCHO. Subjects will be served a breakfast meal with FCHO or without FCHO in a randomly assigned sequence on two separate occasions (visit 1 and visit 2) under fasting conditions.&#xD;
Blood glucose will be measured before (fasting/baseline) and after breakfast test meal intake for 4hrs: 0, 30 min, 60 min, 120 min, and 240 min and then again after the light lunch meal at 30, 60, 90, 120 post lunch.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The tolerability of treatments over 7 days</measure>
    <time_frame>7 days</time_frame>
    <description>After the in-lab study day (visit 1 and visit 2), subjects will go home with the test beverage packs to be consumed daily for 7 days. Subjects will maintain diaries to ensure daily consumption and on day 7 will be asked to complete a brief questionnaire related to gastrointestinal experiences during the week. Identical procedures will take place after both study days, except the assigned treatment will differ.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">29</enrollment>
  <condition>Nutritional Intervention</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Beverage</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A dietary fiber (FCHO)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>15g/BID</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>A dietary fiber (FCHO)</intervention_name>
    <description>15 g twice per day in beverage</description>
    <arm_group_label>A dietary fiber (FCHO)</arm_group_label>
    <other_name>FCHO</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo drink</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>PCB</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  BMI between 18.5 and 29.9 kg/m2, inclusive&#xD;
&#xD;
          -  No clinical evidence of cardiovascular, metabolic, respiratory, renal,&#xD;
             gastrointestinal, or hepatic disease&#xD;
&#xD;
          -  No diabetes&#xD;
&#xD;
          -  No Gastrointestinal issues&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant and/or lactating or planning for pregnancy&#xD;
&#xD;
          -  Allergies or intolerances to foods consumed in the study Fasting blood glucose &gt; 125&#xD;
             mg/dL.&#xD;
&#xD;
          -  Vegetarian&#xD;
&#xD;
          -  Taking over the counter fiber supplements or other supplements that may interfere with&#xD;
             the study procedures or endpoints&#xD;
&#xD;
          -  Taking actively probiotics or purposely taking/ subscribing to a diet high in&#xD;
             prebiotics.&#xD;
&#xD;
          -  Taking prescription medications that may interfere with study procedures or endpoints&#xD;
             (eg., antibiotics)&#xD;
&#xD;
          -  Subjects with unusual dietary habits (e.g. pica)&#xD;
&#xD;
          -  Actively losing weight or trying to lose weight (unstable body weight fluctuations of&#xD;
             &gt; 5 kg in a 60 day period)&#xD;
&#xD;
          -  Excessive exercisers or trained athletes&#xD;
&#xD;
          -  Addicted to drugs and/or alcohol&#xD;
&#xD;
          -  Medically documented psychiatric or neurological disturbances&#xD;
&#xD;
          -  Smokers (past smokers may be allowed if cessation is &gt; 2 years)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Britt Burton-Freeman, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Illinois Institute for Technology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Clinical Nutrition Research Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60616</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 20, 2011</study_first_submitted>
  <study_first_submitted_qc>December 21, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2011</study_first_posted>
  <last_update_submitted>July 26, 2021</last_update_submitted>
  <last_update_submitted_qc>July 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dietary Fiber</keyword>
  <keyword>Blood glucose control</keyword>
  <keyword>Fermentability</keyword>
  <keyword>Tolerability</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

